Ken Griffin Citadel Advisors
AUM
$125B
1-Year Est. Return
4.72%
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
1 Year Est. Return
+4.72%
AUM
$125B
AUM Growth
+$9.45B
(+8.2%)
Holding
7,561
Top Buys
| 1 | +$1.43B | |
| 2 | +$1.04B | |
| 3 | +$1.03B | |
| 4 |
Apple
AAPL
|
+$651M |
| 5 |
Norfolk Southern
NSC
|
+$590M |
Top Sells
| 1 | +$1.24B | |
| 2 | +$721M | |
| 3 | +$706M | |
| 4 |
Edwards Lifesciences
EW
|
+$661M |
| 5 |
Texas Instruments
TXN
|
+$637M |
Sector Composition
| 1 | Technology | 20.06% |
| 2 | Healthcare | 14.01% |
| 3 | Financials | 12.45% |
| 4 | Consumer Discretionary | 10.85% |
| 5 | Industrials | 10.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Direxion Daily S&P Biotech Bull 3X Shares
LABU
$804M
| $8.6M | ﹤0.01% |
+91,850
|
|
||
1552
Palomar
PLMR
$3.57B
| $8.56M | ﹤0.01% |
73,358
+67,007
|
|
||
1553
Alkami Technology
ALKT
$2.38B
| $8.53M | ﹤0.01% |
343,462
+227,901
|
|
||
1554
Nuvation Bio
NUVB
$3.23B
| $8.53M | ﹤0.01% |
2,304,453
-3,228,523
|
|
||
|
LBRX
1555
LB Pharmaceuticals
LBRX
$532M
| $8.52M | ﹤0.01% |
+539,370
|
|
||
1556
Burford Capital
BUR
$2.03B
| $8.52M | ﹤0.01% |
712,028
+440,545
|
|
||
1557
Invesco S&P International Developed Quality ETF
IDHQ
$546M
| $8.45M | ﹤0.01% |
250,981
+162,553
|
|
||
1558
TFS Financial
TFSL
$4.02B
| $8.44M | ﹤0.01% |
640,667
-38,012
|
|
||
|
PRO
1559
DELISTED
PROS Holdings
PRO
| $8.43M | ﹤0.01% |
368,112
+273,030
|
|
||
1560
Arcosa
ACA
$5.45B
| $8.43M | ﹤0.01% |
89,986
+47,608
|
|
||
1561
Ardelyx
ARDX
$1.38B
| $8.42M | ﹤0.01% |
1,528,532
-682,728
|
|
||
1562
Syndax Pharmaceuticals
SNDX
$1.81B
| $8.4M | ﹤0.01% |
546,268
-93,732
|
|
||
1563
Fulgent Genetics
FLGT
$853M
| $8.4M | ﹤0.01% |
371,476
-232,177
|
|
||
1564
Hudbay
HBM
$7.63B
| $8.37M | ﹤0.01% |
551,903
-591,229
|
|
||
1565
Westamerica Bancorp
WABC
$1.25B
| $8.36M | ﹤0.01% |
167,235
+21,491
|
|
||
1566
Churchill Downs
CHDN
$8B
| $8.34M | ﹤0.01% |
85,921
-318,828
|
|
||
1567
Ouster
OUST
$1.33B
| $8.33M | ﹤0.01% |
308,090
-216,205
|
|
||
1568
Frontdoor
FTDR
$4.1B
| $8.32M | ﹤0.01% |
123,696
-310,148
|
|
||
1569
Tapestry
TPR
$25.6B
| $8.3M | ﹤0.01% |
73,341
-80,489
|
|
||
1570
Iovance Biotherapeutics
IOVA
$984M
| $8.29M | ﹤0.01% |
3,820,364
-293,224
|
|
||
1571
TIM SA
TIMB
$9.84B
| $8.28M | ﹤0.01% |
370,982
+333,066
|
|
||
1572
Expro
XPRO
$1.47B
| $8.28M | ﹤0.01% |
696,592
-1,598,222
|
|
||
1573
WSFS Financial
WSFS
$3.14B
| $8.26M | ﹤0.01% |
153,234
+147,856
|
|
||
1574
Celldex Therapeutics
CLDX
$1.7B
| $8.26M | ﹤0.01% |
319,332
-59,406
|
|
||
1575
The Bancorp
TBBK
$3.02B
| $8.23M | ﹤0.01% |
109,904
-487,208
|
|